CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease

<p>Background & Aims</p> <p>End points to determine the efficacy and safety of medical therapies for Crohn’s disease (CD) and ulcerative colitis (UC) are evolving. Given the heterogeneity in current outcome measures, harmonizing end points in a core outcome set for randomized c...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Ma, C, Hanzel, J, Panaccione, R, Sandborn, WJ, D'Haens, GR, Ahuja, V, Atreya, R, Bernstein, CN, Bossuyt, P, Bressler, B, Bryant, RV, Cohen, B, Colombel, J-F, Danese, S, Dignass, A, Dubinsky, MC, Fleshner, PR, Gearry, RB, Hanauer, SB, Hart, A, Kotze, PG, Kucharzik, T, Lakatos, PL, Leong, RW, Magro, F, Panés, J, Peyrin-Biroulet, L, Ran, Z, Regueiro, M, Singh, S, Spinelli, A, Steinhart, AH, Travis, SP, van der Woude, CJ, Yacyshyn, B, Yamamoto, T, Allez, M, Bemelman, WA, Lightner, AL, Louis, E, Rubin, DT, Scherl, EJ, Siegel, CA, Silverberg, MS, Vermeire, S, Parker, CE, McFarlane, SC, Guizzetti, L, Smith, MI, Casteele, NV, Feagan, BG, Jairath, V
Rannpháirtithe: CORE-IBD Collaborators
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: Elsevier 2022